Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?3.3mm NC, SLActive? 8mm, TiZr, NTP: medical device reports filed with FDA

10,140 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

10,140
device reports naming the brand
0% of all MAUDE reports · about 1,485 a year
1,882
reports, 12 months to August 2026
1,889 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 10,140 reports that name the brand "BLT ?3.3mm NC, SLActive? 8mm, TiZr, NTP" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

1,882 reports arrived in the 12 months to August 2026, close to the 1,889 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (70%), loss of osseointegration (25.8%) and fracture (0.9%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0218435Sep 2021: 86Oct 2021: 73Nov 2021: 136Dec 2021: 692022Jan 2022: 135Feb 2022: 105Mar 2022: 123Apr 2022: 117May 2022: 120Jun 2022: 104Jul 2022: 107Aug 2022: 102Sep 2022: 114Oct 2022: 122Nov 2022: 121Dec 2022: 1052023Jan 2023: 103Feb 2023: 118Mar 2023: 102Apr 2023: 121May 2023: 135Jun 2023: 162Jul 2023: 141Aug 2023: 127Sep 2023: 132Oct 2023: 175Nov 2023: 127Dec 2023: 1182024Jan 2024: 110Feb 2024: 155Mar 2024: 113Apr 2024: 163May 2024: 124Jun 2024: 136Jul 2024: 196Aug 2024: 168Sep 2024: 184Oct 2024: 164Nov 2024: 168Dec 2024: 1582025Jan 2025: 152Feb 2025: 135Mar 2025: 157Apr 2025: 71May 2025: 0Jun 2025: 435Jul 2025: 123Aug 2025: 142Sep 2025: 170Oct 2025: 190Nov 2025: 151Dec 2025: 1712026Jan 2026: 137Feb 2026: 136Mar 2026: 127Apr 2026: 129May 2026: 176Jun 2026: 183Jul 2026: 146Aug 2026: 166

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

09491,8972019: 45720192020: 76220202021: 1,04920212022: 1,37520222023: 1,56120232024: 1,83920242025: 1,89720252026: 1,2002026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%10,140
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report86.9%8,810
Voluntary report0%0
User facility report0%0
Distributor report13.1%1,330
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate7,10170%62.8%
Loss of osseointegration2,61525.8%22.4%
Fracturea broken bone910.9%1.6%
Difficult to insertthe device was hard to insert390.4%0.4%
Separation failure140.1%0.1%
Difficult to removethe device was hard to remove40%0%
Unintended movement20%0%
Unstable10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis3,43533.9%
Painpain, site not specified2,09120.6%
Tissue damage7427.3%
Inflammationinflammation7317.2%
Swelling/ edema5465.4%
Hemorrhage/blood loss/bleeding4214.2%
Fistula2562.5%
Hyperresponsive to stimuli2122.1%
Abscessa collection of pus1831.8%
Hypersensitivity/allergic reaction1341.3%
Swellingswelling530.5%
Failure of implant440.4%
Sinus perforation410.4%
Inadequate osseointegration320.3%
Numbnessnumbness290.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?3.3mm NC, SLActive? 8mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports10,1403,924,24126,136,888
Share of that pool—0.3%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer86.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?3.3mm NC, SLActive? 8mm, TiZr, NTP reports

How many FDA reports name BLT ?3.3mm NC, SLActive? 8mm, TiZr, NTP?

10,140 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,882 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (70%), loss of osseointegration (25.8%), fracture (0.9%), difficult to insert (0.4%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (86.9%) and distributor reports (13.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?3.3mm NC, SLActive? 8mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.